Bionime Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 415.12 million compared to TWD 475.65 million a year ago. Net loss was TWD 5.65 million compared to net income of TWD 13.79 million a year ago.

Basic loss per share from continuing operations was TWD 0.09 compared to basic earnings per share from continuing operations of TWD 0.23 a year ago. Diluted loss per share from continuing operations was TWD 0.09 compared to diluted earnings per share from continuing operations of TWD 0.23 a year ago.